Jin Yang Pharmaceutical Co. Ltd Cash Flow Reinvestment Rate
Jin Yang Pharmaceutical Co. Ltd cash flow reinvestment rate. Jin Yang Pharmaceutical Co. Ltd (007370) has a Cash Flow Reinvestment Rate of 0.60x as of June 2026, reinvesting ₩4.84 Billion (capex ₩1.54 Billion plus investments ₩-3.30 Billion) from operating cash flow of ₩8.05 Billion. Explore 007370 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Jin Yang Pharmaceutical Co. Ltd (2018–2025)
Cash flow reinvestment rate of Jin Yang Pharmaceutical Co. Ltd from 2018 to 2025. Historical reinvestment intensity for Jin Yang Pharmaceutical Co. Ltd across 8 annual periods. Explore Jin Yang Pharmaceutical Co. Ltd capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Jin Yang Pharmaceutical Co. Ltd Cash Flow Reinvestment Rate by Year (2018–2025)
Jin Yang Pharmaceutical Co. Ltd cash flow reinvestment rate by year from 2018 to 2025. Year-by-year capital reinvestment analysis for Jin Yang Pharmaceutical Co. Ltd. For the full cash flow conversion analysis, see cash efficiency ratio of Jin Yang Pharmaceutical Co. Ltd.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 2.67x | ₩3.92 Billion | ₩1.46 Billion | ₩3.67 Billion | ▼ -60.8% |
| 2024 | 6.82x | ₩87.22 Billion | ₩12.79 Billion | ₩947.22 Million | ▲ +1120.0% |
| 2023 | 0.56x | ₩4.77 Billion | ₩8.53 Billion | ₩1.53 Billion | ▼ -62.7% |
| 2022 | 1.50x | ₩11.17 Billion | ₩7.45 Billion | ₩3.22 Billion | ▼ -26.9% |
| 2021 | 2.05x | ₩4.04 Billion | ₩1.97 Billion | ₩2.52 Billion | ▲ +191.0% |
| 2020 | 0.71x | ₩4.41 Billion | ₩6.24 Billion | ₩1.36 Billion | ▲ +198.1% |
| 2019 | 0.24x | ₩1.71 Billion | ₩7.21 Billion | ₩736.71 Million | ▼ -41.7% |
| 2018 | 0.41x | ₩429.64 Million | ₩1.06 Billion | ₩327.39 Million | — |